| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |